BioNTech eyes COVID-19 vaccine for 12-15-year-olds from June in Europe

BioNTech said that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June. The German firm's CEO Ugur Sahin asserted that it was 'in the final stretches' of preparing its submission for European regulatory approval.